These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16199684)

  • 1. Poor formulation information in published pediatric drug trials.
    Standing JF; Khaki ZF; Wong IC
    Pediatrics; 2005 Oct; 116(4):e559-62. PubMed ID: 16199684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inappropriate oral formulations and information in paediatric trials.
    Pandit S; Shah U; Kirby DJ; Nunn T; Tuleu C
    Arch Dis Child; 2010 Sep; 95(9):754-6. PubMed ID: 20605870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methodology standards associated with quality reporting in clinical studies in pediatric surgery journals.
    Thakur A; Wang EC; Chiu TT; Chen W; Ko CY; Chang JT; Atkinson JB; Fonkalsrud EW; Grosfeld JL
    J Pediatr Surg; 2001 Aug; 36(8):1160-4. PubMed ID: 11479847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The International Liaison Committee on Resuscitation (ILCOR) consensus on science with treatment recommendations for pediatric and neonatal patients: pediatric basic and advanced life support.
    International Liaison Committee on Resuscitation
    Pediatrics; 2006 May; 117(5):e955-77. PubMed ID: 16618790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of Canadian general pediatric dosing publications.
    Dayneka N
    Can J Clin Pharmacol; 2003; 10(3):107-10. PubMed ID: 14506508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quality assessment of randomized clinical trials in pediatric orthopaedics.
    Dulai SK; Slobogean BL; Beauchamp RD; Mulpuri K
    J Pediatr Orthop; 2007; 27(5):573-81. PubMed ID: 17585270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting of ethical review of clinical research submitted to the Journal of the American Academy of Dermatology.
    Perkins AC; Choi JM; Kimball AB
    J Am Acad Dermatol; 2007 Feb; 56(2):279-84. PubMed ID: 17224370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of industry sponsorship to published outcomes in gastrointestinal clinical research.
    Brown A; Kraft D; Schmitz SM; Sharpless V; Martin C; Shah R; Shaheen NJ
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1445-51. PubMed ID: 17101295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting adverse events in randomized controlled trials.
    Nuovo J; Sather C
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):349-51. PubMed ID: 16998947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting on methods in clinical trials.
    DerSimonian R; Charette LJ; McPeek B; Mosteller F
    N Engl J Med; 1982 Jun; 306(22):1332-7. PubMed ID: 7070458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving pediatric dosing through pediatric initiatives: what we have learned.
    Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
    Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European perspectives on pediatric formulations.
    Breitkreutz J
    Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are studies reporting significant results more likely to be published?
    Koletsi D; Karagianni A; Pandis N; Makou M; Polychronopoulou A; Eliades T
    Am J Orthod Dentofacial Orthop; 2009 Nov; 136(5):632.e1-5; discussion 632-3. PubMed ID: 19892276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of false-positive results in orthopaedic surgical trials.
    Bhandari M; Whang W; Kuo JC; Devereaux PJ; Sprague S; Tornetta P
    Clin Orthop Relat Res; 2003 Aug; (413):63-9. PubMed ID: 12897597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An absence of pediatric randomized controlled trials in general medical journals, 1985-2004.
    Cohen E; Uleryk E; Jasuja M; Parkin PC
    J Clin Epidemiol; 2007 Feb; 60(2):118-23. PubMed ID: 17208117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.